Yunnan Baiyao Group Co Ltd
SZSE:000538

Watchlist Manager
Yunnan Baiyao Group Co Ltd Logo
Yunnan Baiyao Group Co Ltd
SZSE:000538
Watchlist
Price: 60.28 CNY 0.05%
Market Cap: 107.6B CNY
Have any thoughts about
Yunnan Baiyao Group Co Ltd?
Write Note

Yunnan Baiyao Group Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Yunnan Baiyao Group Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Receivables
ÂĄ10.1B
CAGR 3-Years
15%
CAGR 5-Years
40%
CAGR 10-Years
27%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Receivables
ÂĄ3.2B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Receivables
ÂĄ809.6m
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
15%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Receivables
ÂĄ6.2B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
14%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Accounts Receivables
ÂĄ408.1m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Receivables
ÂĄ98.4m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Yunnan Baiyao Group Co Ltd
Glance View

Market Cap
107.6B CNY
Industry
Pharmaceuticals

Yunnan Baiyao Group Co Ltd is a captivating story of fusion between traditional Chinese medicine and modern business acumen. Rooted in Yunnan province's rich heritage, the company traces its origins back to the early 1900s when a local healer discovered a potent remedy for addressing wounds and reducing bleeding. Over the years, this original formula, a tightly-kept secret, evolved into a cornerstone product that propelled Yunnan Baiyao into the spotlight. As the company expanded, it embraced an adept strategy of integrating traditional formulations with contemporary pharmaceutical practices, enabling it to carve out a niche within the global health sector. Today, Yunnan Baiyao Group boasts a diversified portfolio that extends beyond its flagship product to include various health care, personal care, and even veterinary offerings. Its revenue model intricately weaves together streams from over-the-counter remedies, prescription medications, and consumer healthcare products. The company's innovative stride into the realms of cosmetics and toothpaste indicates its agility in adapting ancient knowledge for contemporary consumer demands. Strategic marketing emphasizes the unique heritage and trusted efficacy of its products, helping Yunnan Baiyao solidify its standing in a competitive market. As it continues to grow, the group remains a compelling example of how deeply-rooted tradition can be harnessed to drive a modern enterprise to sustained profitability.

Intrinsic Value
69.79 CNY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Yunnan Baiyao Group Co Ltd's Accounts Receivables?
Accounts Receivables
10.1B CNY

Based on the financial report for Sep 30, 2024, Yunnan Baiyao Group Co Ltd's Accounts Receivables amounts to 10.1B CNY.

What is Yunnan Baiyao Group Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
27%

Over the last year, the Accounts Receivables growth was 4%. The average annual Accounts Receivables growth rates for Yunnan Baiyao Group Co Ltd have been 15% over the past three years , 40% over the past five years , and 27% over the past ten years .

Back to Top